We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Improvement in Brain Oxygenation and Clinical Improvement in Patients With Strokes Treated With Papaverine Hydrochloride

John S. Meyer, MD; Fumio Gotoh, MD; John Gilroy, MD; Nasaharu Nara, MD
JAMA. 1965;194(9):957-961. doi:10.1001/jama.1965.03090220013003.
Text Size: A A A
Published online

Intravenous injection of papaverine hydrochloride in doses of 64 mg was found to increase the oxygen available to the brain in subjects suffering from acute stroke (cerebral thromboembolism) proven by arteriography. This was established by continuous measurement of cerebral arteriovenous differences for oxygen pressure and saturation. Both the latter showed significant increases. Cerebral venous carbon dioxide pressure (Pco2) decreased and cerebral venous pH increased significantly. Analysis of cerebral arteriovenous differences indicated that the increase in oxygen available to the brain was due to increased cerebral blood flow despite some decrease in arterial Pco2 due to hyperventilation. The increase in cerebral blood flow occurred even in the presence of high Pco2 values and was greater in older subjects than in younger subjects. Clinical evaluation of two groups of subjects with acute stroke (proven by arteriography) who were selected for treatment in a random manner indicated that the group of subjects who underwent treatment with papaverine improved more than those that did not receive this drug (0.01 <P<0.05).


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.